Effects of administration of gonadotropin-releasing hormone at artificial insemination on conception rates in dairy cows

Gonadotropin-Releasing Hormone (GnRH) and Its Agonists in Bovine Reproduction II: Diverse Applications during Insemination, Post-Insemination, Pregnancy, and Postpartum Periods

The administration of GnRH and its agonists benefits various aspects of bovine reproductive programs, encompassing physiological stages such as estrous synchronization, post-insemination, pregnancy, and the postpartum period. The positive impact of GnRH administration in overcoming challenges like repeat breeder cows, early embryonic loss prevention, and the management of cystic ovarian disease (COD) is thoroughly surveyed. Furthermore, this review focuses on the significance of GnRH administration during the postpartum period, its role in ovulation induction, and how it enhances the productivity of embryo transfer (ET) programs. An emerging feature of this field is introduced, focusing on nano-drug delivery systems for GnRH agonists, and the potential benefits that may arise from such advancements are highlighted. While this review offers valuable insights into various applications of GnRH in bovine reproduction, it emphasizes the crucial need for further research and development in this field to advance reproductive efficiency and health management in dairy cattle.

Synchronization of breeding and its impact on genetic parameters and evaluation of female fertility traits

Achieving an acceptable level of fertility in herds is difficult for many dairy producers because identifying cows in estrus has become challenging owing to poor estrus expression, increased herd size, and lack of time and skilled labor for estrus detection. As a result, synchronization of estrus is often used to manage reproduction. The aims of this study were (1) to identify artificial inseminations (AI) that were performed following synchronization and (2) to assess the effect of synchronization on genetic parameters and evaluation of fertility traits. This study used breeding data collected between 1995 and 2021 from over 4,600 Australian dairy herds that had at least 30 matings per year. Because breeding methods were not reported, the recording pattern of breeding dates showing a large proportion of the total AI being recorded on a single date of the year served as an indicator of synchronization. First, the proportion of AI recorded on each day of the year was calculated for each herd-year. Subsequently, synchronization was defined when a herd with, for instance, only 30 matings in a year, had at least 0.20 or more AI on the same day. As the number of breedings in a herd-year increased, the threshold for classifying AI was continuously reduced from 0.20 to as low as 0.03 under the assumption that mating of many cows on a single date becomes increasingly difficult without synchronization. From the current data, we deduced that 0.11 of all AI were possibly performed following synchronization (i.e., timed AI, TAI). The proportion of AI classified as TAI increased over time and with herd size. Although the deviation from equal numbers of mating on 7 d of the week was not used for classifying AI, 0.44 of AI being categorized as TAI were performed on just 2 d of the week. When data classified as TAI were used for estimating genetic parameters and breeding values, the interval between calving and first service (CFS) was found to be the most affected trait. The phenotypic and additive genetic variance and heritability, as well as variability and reliability of estimated breeding values of bulls and cows for CFS were lower for TAI than for AI performed following detected estrus (i.e., estrus-detected AI, EAI). For calving interval, first service nonreturn rate (FNRR), and successful calving rate to first service, genetic correlations between the same trait measured in TAI and EAI were close to 1, in contrast to 0.55 for CFS. The lower genetic variances and heritabilities for FNRR and calving interval in TAI than in EAI suggests that synchronization reduces the genetic variability of fertility. In conclusion, TAI makes CFS an ineffective measure of fertility. One approach to minimize this effect on genetic evaluations is to identify TAI (using the method described for example) and then set the CFS of these cows as missing records when running multitrait genetic evaluations of fertility traits that include CFS. In the long term, the most practical and accurate way to reduce the effect of synchronization on genetic evaluations is to record TAI along with mating data.

GnRH34: An alternative for increasing pregnancy in timed AI beef cows

Two experiments evaluated the effects of gonadotropin releasing hormone (GnRH) treatment on fertility of suckled Nelore beef cows treated with an estradiol/progesterone (P4)-based protocol for timed artificial insemination (TAI). Experiment 1 was designed to determine the effect of GnRH administered 34 h after P4 insert removal (GnRH34) on time of ovulation. Suckled cows (n = 34) were treated with 2 mg estradiol benzoate (EB) and an intravaginal insert containing 1.9 g of P4. Eight days later, P4 inserts were removed, and all cows received 150 μg of d-cloprostenol (prostaglandin F2 alpha analogue), 300 IU of eCG, and 1 mg of estradiol cypionate (ECP). On Day 9 (05:00 p.m.), cows were randomly distributed, according to the diameter of the pre-ovulatory follicle, in two treatments: 1) GnRH (n = 17) cows that received 10.5 μg of buserelin acetate, or 2) no further treatment (control, n = 17). Cows treated with GnRH 34 h after P4 insert removal ovulated earlier (P = 0.02) than control cows (66 ± 0.0 and 77.2 ± 4.3 h). Experiment 2 was designed to determine the effect of GnRH34 on the fertility of suckled beef cows. Nelore cows (n = 506) were treated as Experiment 1. On Day 8, cows were painted in the sacrocaudal region to identify cows that displayed estrus. On Day 9 (05:00 p.m.), cows were randomized to receive same treatment as Experiment 1, control (n = 252), or GnRH (n = 254). All cows were TAI 48 h after P4 insert removal. At TAI, estrus was evaluated, and deemed to have occurred in cows without a tail-head chalk mark (>75% paint loss). Cows treated with GnRH 34 h after P4 insert removal had greater (P = 0.01) pregnancy per AI (P/AI) than cows that only received ECP (63.0% and 50.4%). No difference (P = 0.5) was observed in the proportion of cows that displayed estrus between treatments. Furthermore, cows that displayed estrus had greater (P < 0.01) P/AI than cows that did not. Treatment with GnRH, given at 34 h after P4 insert removal, increased (P < 0.05) P/AI in cows that did not show estrus at TAI. In summary, treatment with GnRH 34 h after P4 insert removal was associated with earlier ovulation and resulted in greater P/AI in suckled Nelore cows treated with an estradiol/P4-based protocol for TAI.

Impact of GnRH administration at the time of artificial insemination on conception risk and its association with estrous expression

Cows with reduced estrous expression have compromised fertility. The aim of this study was to determine whether the administration of GnRH at the time of artificial insemination (AI) would affect ovulation rates and the fertility of animals expressing estrous behavior of lesser intensity. Cows were enrolled at the time of estrus from 3 farms (n = 2,607 estrus events; farm A: 1,507, farm B: 429, farm C: 671) and randomly assigned to receive GnRH at AI or not (control). The intensity of estrous expression, monitored through leg-mounted activity monitors, was determined using the maximum activity during estrus; estrous expression was categorized as greater or lower relative to the farm median. On farm A, cows were assessed at alert, and 24 h, 48 h, and 7 d post-alert for ovulation using ultrasonography. Pregnancy per AI was confirmed at 35 ± 7 d post-estrus for cows that were inseminated. Differences between treatments were tested using the GLIMMIX procedure of SAS. Treatment with GnRH at the time of AI increased pregnancy per AI (41.3 ± 1.6 vs. 35.7 ± 1.7%). An interaction between treatment and estrous expression on pregnancy per AI was found. Control cows with greater estrous expression had greater pregnancy per AI than those with lesser expression, whereas GnRH administration increased pregnancy per AI for cows with lesser estrous expression but not those with greater expression (GnRH, greater intensity: 43.5 ± 2.1; GnRH, lesser intensity: 37.8 ± 2.2; control, greater intensity: 42.6 ± 2.2; control, lesser intensity: 31.0 ± 2.2%). A higher proportion of cows with greater estrous expression that were administered GnRH at AI were found to ovulate by 48 h and 7 d post-estrus; however, ovulation of cows with lesser estrous expression was unaffected by GnRH administration. In conclusion, fertility of cows with reduced estrous expression may be increased using GnRH at the time of AI; however, increased ovulation rates do not seem to be the direct mechanism behind this relationship.

Timed artificial insemination plus heat II: gonadorelin injection in cows with low estrus expression scores increased pregnancy in progesterone/estradiol-based protocol

The use of tail chalk and estrus/heat expression scores (HEATSC) evaluation is instrumental in identifying cows with greater estrus expression and greater artificial insemination pregnancy rates (P/AI) in cows submitted to timed artificial insemination (TAI), and cows with low or no estrus expression present lower P/AI. It was intended in this study to improve the pregnancy rates in TAI for Bos indicus beef cows, and gonadotrophin-releasing hormone (GnRH) injection was hypothesized to increase pregnancy rates in a TAI program for cows submitted to progesterone-estradiol-based protocols with low or no estrus expression, evaluated by HEATSC. Cows (n= 2284) received a progesterone device and 2 mg estradiol benzoate, after 8 days the device was removed and 1 mg estradiol cypionate, 150 μg of d-cloprostenol and 300 IU equine chorionic gonadotropin was administered. All cows were marked with chalk and HEATSC evaluated (scales 1 to 3) at TAI performed on day 10. Animals with HEATSC1 and HEATSC2 (n= 937) received 100 μg de gonadorelin (GNRH group; n= 470), or 1 ml saline (Control group; n= 467), and cows with HEATSC3 (named HEAT group; n= 1347) received no additional treatment. The larger dominant follicle, evaluated on day 8and at TAI (day 10), was greater in HEAT group (P= 0.0145 and P <0.001, respectively). Corpus luteum (CL) area and progesterone concentration was evaluated on day 17, and CL area was larger in HEAT group, intermediary in Control and lower in GnRH group (Control= 2.68 cm2, GnRH= 2.37 cm2, HEAT group= 3.07 cm2, P <0.001). Greater progesterone concentrations were found in HEAT group than in Control and GnRH groups (Control= 4.74 ng/ml, GnRH= 4.29 ng/ml, HEAT group= 6.08 ng/ml, P<0.001). There was a difference in ovulation rate, greater in HEAT group than GnRH and Control groups (Control= 72.5%; GnRH= 81.25%; HEAT group= 90.71%; P= 0.0024). Artificial insemination pregnancy rates was greater in HEAT group (57.09% (769/1347) than in Control and GNRH groups, with positive effect of GnRH injection at the time of TAI in P/AI (Control= 36.18% (169/467), GnRH= 45.95% (216/470); P<0.0001). In conclusion, GnRH application in cows with low HEATSC (1 and 2) is a simple strategy, requiring no changes in TAI management to increase pregnancy rates in postpartum beef cows submitted to progesterone-estradiol-based TAI protocols, without reaching, however, the pregnancy rates of cows that demonstrate high estrus expression at the TAI.

[Use of gonadorelin[6-D-Phe] at day 0 or 12 after insemination to increase the conception rate in a large dairy herd in Saxony/Germany]

OBJECTIVE

To increase conception rates in lactating dairy cows by the application of a gonadotropin-releasing-hormone (GnRH)-agonist after insemination.

MATERIAL AND METHODS

A total of 3125 inseminations of 1634 cows were included in this study. The animals were randomized into three groups at the time of insemination (day 0) using the final numeral of the ear-tag number: The cows of the GnRH0 group were treated using 100 μg gonadorelin[6-D-Phe] intramuscularly immediately after insemination (day 0), while those of the GnRH12 group were treated similarly at day 12. The cows of the control group received no hormonal treatment after insemination. An examination for pregnancy was performed at day 28 using transrectal ultrasonography. Analysis of the data sets was conducted for the number of inseminations (NI) 1-4 and for the last observed insemination of the respective cow during the experimental period, respectively. In a second step, statistical analysis was performed for the first service of cows with a lactation number of 1 versus > 1, with emphasis on the daily milk yield. In addition, a metritis diagnosed after the previous parturition was investigated as a possible factor influencing NI 1.

RESULTS

Pregnancy risk at day 28 was decreased for NI 2 (n = 792) in the GnRH0 group compared to the control group (odds ratio [OR] = 0.69; 95% confidence interval [CI95] = 0.5-1.0; p = 0.04). A similar observation was found for NI 3 (n = 495) for the GnRH12 group (OR = 0.54; CI95 = 0.3-0.9; p = 0.01). In contrast, the pregnancy risk was increased for cows with a lactation number ≥ 2 and with a daily milk yield ≥ 42.5 kg (7-day-mean at day 0) at the first service (n = 364) by treatment with gonadorelin immediately after insemination (OR = 2.0; CI95 = 1.2-3.4; p = 0.01). No significant differences in the pregnancy risk were observed for the remaining analysed classes.

CONCLUSION

An increased conception rate was only achieved for the first service of high-yield dairy cows (lactation number ≥ 2) by gonadorelin treatment at day 0. Presumably, the higher incidence of delayed ovulations in this group was treated successfully by gona- dorelin administration.

Dynamics of Progesterone, TNF- α , and a Metabolite of PGF2 α in Blood Plasma of Beef Cows following Embryo Transfer

Lactating beef cows previously synchronized for estrus (d 0) were assigned to four treatments to assess their effectiveness in increasing blood progesterone (P4) and its effects on tumor necrosis factor-α (TNF-α) and prostaglandin F2α (PGF2α) after the transfer of embryos. At the time of transfer (d 7), cows received no treatment (control; n = 16), a controlled internal drug releasing device (CIDR; n = 16), human chorionic gonadotropin (hCG; n = 15), or gonadotropin releasing hormone (GnRH; n = 15). Blood samples were taken on d 7, 14, and 21 for analysis of P4 and tumor necrosis factor-α (TNF-α). Blood was collected (every 15 min for 2 h) in half the animals in each treatment group on d 14 and the remaining half on d 21 for analysis of prostaglandin F2α metabolite (PGFM). Retention rates were 56.2, 62.5, 46.7, and 13.3% for cows in the control, CIDR, hCG, and GnRH groups, respectively. Progesterone was greater (P ≤ 0.05) in cows receiving hCG compared to others on d 14. Progesterone in all treatment groups increased from d 7 to d 14 and declined (P ≤ 0.05) from d 14 to d 21. Contrary to pregnant cows, P4 and TNF-α declined from d 7 to d 21 in nonpregnant cows (P ≤ 0.05). Although PGFM increased by d 21, there was no difference between pregnant and nonpregnant cows.